Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Lucid Diagnostics Inc (NQ: LUCD ) 0.8004 +0.0026 (+0.33%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Lucid Diagnostics Inc < Previous 1 2 3 Next > LUCD Stock Earnings: Lucid Diagnostics Beats EPS, Misses Revenue for Q2 2024 August 12, 2024 LUCD stock results show that Lucid Diagnostics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. Via InvestorPlace 3 Hypergrowth Stocks That Speculators Should Keep Tabs On July 29, 2024 While a high-risk proposition, these hypergrowth stocks can potentially bring enormous returns in a short period of time. Via InvestorPlace Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for May 2024 May 20, 2024 Although the concept of penny stocks to buy is extremely risky, these ideas have the advantage of analysts’ positive assessments. Via InvestorPlace LUCD Stock Earnings: Lucid Diagnostics Beats EPS, Misses Revenue for Q1 2024 May 13, 2024 LUCD stock results show that Lucid Diagnostics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. Via InvestorPlace 12 Health Care Stocks Moving In Tuesday's Intraday Session April 30, 2024 Via Benzinga Earnings Preview: Lucid Diagnostics March 22, 2024 Via Benzinga Earnings Preview For Lucid Diagnostics November 10, 2023 Via Benzinga Where Lucid Diagnostics Stands With Analysts May 17, 2023 Via Benzinga Preview: Lucid Diagnostics's Earnings May 12, 2023 Via Benzinga Lucid Diagnostics Earnings Perspective: Return On Capital Employed March 15, 2023 Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session April 29, 2024 Via Benzinga 3 Penny Stocks That Could Make a Big Comeback by the End of Q2 April 19, 2024 Although penny stocks to rebound represent one of the riskiest market categories, there could be some substance here. Via InvestorPlace LUCD Stock Earnings: Lucid Diagnostics Beats EPS, Misses Revenue for Q4 2023 March 25, 2024 LUCD stock results show that Lucid Diagnostics beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023. Via InvestorPlace Earnings Scheduled For March 25, 2024 March 25, 2024 Companies Reporting Before The Bell • Bitcoin Depot (NASDAQ:BTM) is expected to report quarterly loss at $0.08 per share on revenue of $161.50 million. Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session February 19, 2024 Via Benzinga A Preview Of Lucid Diagnostics's Earnings March 13, 2023 Via Benzinga PAVmed, Lucid Diagnostics Pause Some Development Programs, Announce Layoffs January 18, 2023 Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session January 18, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session March 24, 2023 Via Benzinga Why PAVmed Shares Are Falling Today January 18, 2023 PAVmed Inc. (NASDAQ: PAVM) shares are trading lower after the company announced a workforce reduction of roughly 20% alongside other cost-cutting measures. Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session January 17, 2023 Via Benzinga PAVmed and Lucid Diagnostics Provide Strategic Business Update January 17, 2023 From PAVmed Inc. Via Business Wire Earnings Scheduled For November 13, 2023 November 13, 2023 Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter. Via Benzinga Earnings Scheduled For August 14, 2023 August 14, 2023 Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million. Via Benzinga PAVmed and Lucid Diagnostics to Provide Strategic Business Update January 11, 2023 From PAVmed Inc. Via Business Wire PAVmed Partners with Novosound on Ultrasound Imaging Technology December 22, 2022 From PAVmed Inc. Via Business Wire PAVmed Digital Health Subsidiary Veris Health Launches Veris Cancer Care Platform December 15, 2022 From PAVmed Inc. Via Business Wire Lucid Diagnostics Selected as Finalist for Medtech Company of the Year 2022 by Medical Device + Diagnostic Industry December 08, 2022 From Lucid Diagnostics Inc. Via Business Wire Lucid Diagnostics Presents Real-World EsoCheck Data at the American Association for Cancer Research December 01, 2022 From Lucid Diagnostics Inc. Via Business Wire PAVmed Provides Business Update and Third Quarter 2022 Financial Results November 15, 2022 From PAVmed Inc. Via Business Wire < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.